patients severe angina stem cells blood injected heart therapy carried chicago northwestern university halved number bouts angina chest pain uk experts stressed work early stage potential longer benefit unknown procedure carry risk suspected causing heart muscle damage patients reported bone chest pain study carried 167 patients refraction angina not respond standard treatment given high low dose stem cell infusions dummy injection year patients low dose group average 6.3 episodes pain week compared 11 week given placebo jab length time able tolerate exercise improved 139 seconds months compared improvement 69 seconds placebo group significant benefit receiving higher dose stem cells lead